Annual SGA
$3.41 M
-$3.67 M-51.79%
December 1, 2024
Summary
- As of March 12, 2025, CMMB annual SGA is $3.41 million, with the most recent change of -$3.67 million (-51.79%) on December 1, 2024.
- During the last 3 years, CMMB annual SGA has fallen by -$2.62 million (-43.44%).
- CMMB annual SGA is now -70.47% below its all-time high of $11.56 million, reached on December 31, 2022.
Performance
CMMB SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$802.00 K
-$72.00 K-8.24%
December 1, 2024
Summary
- As of March 12, 2025, CMMB quarterly SGA is $802.00 thousand, with the most recent change of -$72.00 thousand (-8.24%) on December 1, 2024.
- Over the past year, CMMB quarterly SGA has dropped by -$134.00 thousand (-14.32%).
- CMMB quarterly SGA is now -75.99% below its all-time high of $3.34 million, reached on June 30, 2022.
Performance
CMMB Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$391.01 M
-$13.95 M-3.70%
December 1, 2024
Summary
- As of March 12, 2025, CMMB TTM SGA is -$391.01 million, with the most recent change of -$13.95 million (-3.70%) on December 1, 2024.
- Over the past year, CMMB TTM SGA has dropped by -$396.86 million (-6781.58%).
- CMMB TTM SGA is now -1550.16% below its all-time high of -$23.70 million.
Performance
CMMB TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CMMB Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -51.8% | -14.3% | -6781.6% |
| 3 y3 years | -43.4% | -14.3% | -6781.6% |
| 5 y5 years | +164.9% | -14.3% | -6781.6% |
CMMB Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -70.5% | at low | -76.0% | +6.8% | -223.5% | at low |
| 5 y | 5-year | -70.5% | +164.9% | -76.0% | +427.6% | -1550.2% | at low |
| alltime | all time | -70.5% | +164.9% | -76.0% | +427.6% | -1550.2% | at low |
Chemomab Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $3.41 M(-51.8%) | $802.00 K(-8.2%) | $3.45 M(+1.5%) |
| Sep 2024 | - | $874.00 K(+4.0%) | $3.40 M(-3.3%) |
| Jun 2024 | - | $840.00 K(-10.3%) | $3.52 M(-39.9%) |
| Mar 2024 | - | $936.00 K(+24.6%) | $5.85 M(-17.3%) |
| Dec 2023 | $7.08 M(-38.8%) | $751.00 K(-24.1%) | $7.08 M(-22.0%) |
| Sep 2023 | - | $990.00 K(-68.8%) | $9.07 M(-17.3%) |
| Jun 2023 | - | $3.17 M(+46.9%) | $10.98 M(-1.5%) |
| Mar 2023 | - | $2.16 M(-21.3%) | $11.14 M(-3.6%) |
| Dec 2022 | $11.56 M | $2.75 M(-5.1%) | $11.56 M(+0.9%) |
| Sep 2022 | - | $2.89 M(-13.4%) | $11.45 M(+15.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $3.34 M(+29.7%) | $9.96 M(+23.5%) |
| Mar 2022 | - | $2.58 M(-2.5%) | $8.07 M(+33.7%) |
| Dec 2021 | $6.03 M(+368.4%) | $2.64 M(+88.1%) | $6.03 M(+47.9%) |
| Sep 2021 | - | $1.40 M(-2.9%) | $4.08 M(+42.2%) |
| Jun 2021 | - | $1.45 M(+166.8%) | $2.87 M(+71.0%) |
| Mar 2021 | - | $542.00 K(-21.2%) | $1.68 M(+30.3%) |
| Dec 2020 | $1.29 M | $688.00 K(+254.6%) | $1.29 M(+114.7%) |
| Sep 2020 | - | $194.00 K(-23.6%) | $600.00 K(+47.8%) |
| Jun 2020 | - | $254.00 K(+67.1%) | $406.00 K(+167.1%) |
| Mar 2020 | - | $152.00 K | $152.00 K |
FAQ
- What is Chemomab Therapeutics annual SGA?
- What is the all time high annual SGA for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual SGA year-on-year change?
- What is Chemomab Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly SGA year-on-year change?
- What is Chemomab Therapeutics TTM SGA?
- What is the all time high TTM SGA for Chemomab Therapeutics?
- What is Chemomab Therapeutics TTM SGA year-on-year change?
What is Chemomab Therapeutics annual SGA?
The current annual SGA of CMMB is $3.41 M
What is the all time high annual SGA for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual SGA is $11.56 M
What is Chemomab Therapeutics annual SGA year-on-year change?
Over the past year, CMMB annual SGA has changed by -$3.67 M (-51.79%)
What is Chemomab Therapeutics quarterly SGA?
The current quarterly SGA of CMMB is $802.00 K
What is the all time high quarterly SGA for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly SGA is $3.34 M
What is Chemomab Therapeutics quarterly SGA year-on-year change?
Over the past year, CMMB quarterly SGA has changed by -$134.00 K (-14.32%)
What is Chemomab Therapeutics TTM SGA?
The current TTM SGA of CMMB is -$391.01 M
What is the all time high TTM SGA for Chemomab Therapeutics?
Chemomab Therapeutics all-time high TTM SGA is -$23.70 M
What is Chemomab Therapeutics TTM SGA year-on-year change?
Over the past year, CMMB TTM SGA has changed by -$396.86 M (-6781.58%)